(1R,9S)-(-)-β-Hydrastine - CAS 118-08-1
Catalog number:
118-08-1
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C21H21NO6
Molecular Weight:
383.39
COA:
Inquire
Targets:
Others
Description:
Hydrastine, a natural alkaloid compound, could be used as a dopamine biosynthesis inhibitor.
Publictions citing BOC Sciences Products
  • >> More
Purity:
99%
Appearance:
Powder
Synonyms:
(1R,9S)-(-)-beta-Hydrastine;Hydrastine base
Solubility:
10 mM in H2O (free soluble)
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
Hydrastine could be used as a dopamine biosynthesis inhibitor.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
Boiling Point:
548.8ºC at 760mmHg
Melting Point:
132ºC
Density:
1.339g/cm3
InChIKey:
ZCTQGTTXIYCGGC-UHFFFAOYSA-N
InChI:
InChI=1S/C14H12O3/c15-13-9-5-4-8-12(13)14(16)17-10-11-6-2-1-3-7-11/h1-9,15H,10H2
Canonical SMILES:
C1=CC=C(C=C1)COC(=O)C2=CC=CC=C2O
1.Enantio-selective inhibition of (1R,9S)- and (1S,9R)-beta-hydrastines on dopamine biosynthesis in PC12 cells.
Yin SY1, Kim YM, Lee JJ, Jin CM, Yang YJ, Ma JJ, Kang MH, Kai M, Lee MK. Neuropharmacology. 2004 Dec;47(7):1045-52.
The inhibitory effects of (1R,9S)- and (1S,9R)-enantiomers of beta-hydrastine (BHS) on dopamine biosynthesis in PC12 cells were investigated. (1R,9S)-BHS decreased the intracellular dopamine content with the IC50 value of 14.3 microM at 24 h, but (1S,9R)-BHS did not. (1R,9S)-BHS was not cytotoxic at concentrations up to 250 microM towards PC12 cells. In these conditions, (1R,9S)-BHS inhibited tyrosine hydroxylase (TH) activity mainly in a concentration-dependent manner (33% inhibition at 20 microM) and decreased TH mRNA level in PC12 cells. The inhibitory patterns of dopamine content and TH activity by (1R,9S)-BHS showed similar behavioral curves. (1R,9S)-BHS at 10-50 microM also reduced the intracellular cyclic AMP level and Ca2+ concentration. In addition, treatment of L-DOPA at 20-50 microM for 24 h increased the intracellular dopamine content to 198-251% compared with the control in PC12 cells. However, the increase in dopamine levels induced by L-DOPA (20-50 microM) was reduced when L-DOPA was combined with (1R,9S)-BHS (10-50 microM).
2.Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells.
Kim SH1, Shin JS, Lee JJ, Yin SY, Kai M, Lee MK. Planta Med. 2001 Oct;67(7):609-13.
The effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells were investigated. Treatments of PC12 cells with (1R,9S)-beta-hydrastine hydrochloride [(+)-beta-hydrastine HCl] and (1R,9S)-beta-hydrastine [(-)-beta-hydrastine] showed 50.6 % and 33.1 % inhibition of dopamine content at a concentration of 10 microM for 48 h. However, (1S,9R)-beta-hydrastine [(+)-beta-hydrastine] and hydrastinine hydrochloride did not reduce dopamine content. The IC(50) values of (1R,9S)-beta-hydrastine hydrochloride and (1R,9S)-beta-hydrastine were 9.3 microM and 20.7 microM , respectively. Next, the intracellular mechanisms of (1R,9S)-beta-hydrastine hydrochloride in PC12 cells were investigated. Dopamine content decreased at 6 h and reached a minimal level at 24 h after the exposure of PC12 cells to 20 microM (1R,9S)-beta-hydrastine hydrochloride. Tyrosine hydroxylase (TH) activity was inhibited at 6 h following the treatment with (1R,9S)-beta-hydrastine hydrochloride, and was maintained at a reduced level for up to 36 h in PC12 cells (17 - 27 % inhibition at 20 microM), whereas TH mRNA level was not found to alter for 24 h.
3.Effects of (1R,9S)-beta-hydrastine on l-DOPA-induced cytotoxicity in PC12 cells.
Yin SY1, Lee JJ, Kim YM, Jin CM, Yang YJ, Kang MH, Kai M, Lee MK. Eur J Pharmacol. 2004 Mar 19;488(1-3):71-7.
(1R,9S)-beta-Hydrastine in lower concentrations of 10-50 microM inhibits dopamine biosynthesis in PC12 cells. In this study, the effects of (1R,9S)-beta-hydrastine on L-DOPA (L-3,4-dihydroxyphenylalanine)-induced cytotoxicity in PC12 cells were investigated. (1R,9S)-Hydrastine at concentrations up to 250 microM did not reduce cell viability. However, at concentrations higher than 500 microM it caused cytotoxicity in PC12 cells, as determined with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, TUNEL (terminal deoxynucleotidyltransferase dUTP nick-end labeling) method and flow cytometry. Exposure of PC12 cells to cytotoxic concentrations of (1R,9S)-beta-hydrastine (500 and 750 microM) in combination with L-DOPA (20, 50 and 100 microM) after 24 or 48 h resulted in a significant decrease in cell viability compared with the effects of (1R,9S)-beta-hydrastine or L-DOPA alone, and apoptotic cell death was observed.
4.Effects of (1R,9S)-beta-hydrastine on intracellular calcium concentration in PC12 ce
Yin SY1, Kim YM, Lee JJ, Jin CM, Yang YJ, Park SK, Yoo SK, Lee MK. Biol Pharm Bull. 2007 Aug;30(8):1547-50.
(1R,9S)-beta-hydrastine (BHS) decreases the basal intracellular Ca(2+) concentration ([Ca(2+)](i)) in PC12 cells.(5) This study examined the effects of (1R,9S)-BHS on [Ca(2+)](i) in PC12 cells. (1R,9S)-BHS at 10-100 microM in combination with a high extracellular K+ level (56 mM) inhibited the release of dopamine in a concentration-dependent manner with an IC(50) value of 66.5 microM. BHS at 100 microM inhibited the sustained increase in [Ca(2+)](i) induced by a high K+ level (56 mM), and had an inhibitory effect on the 2 microM nifedipine-induced blockage of the K+ -stimulated sustained increase in [Ca(2+)](i). In addition, (1R,9S)-BHS at 100 microM prevented the rapid and sustained increase in [Ca(2+)](i) elicited by 20 mM caffeine, but did not have an effect on the increase induced by 1 microM thapsigargin, in the presence of external Ca(2+). These results suggest that the active sites of (1R,9S)-BHS are mainly L-type Ca(2+) channels and caffeine-sensitive Ca(2+)-permeable channels in PC12 cells.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


HJC0197
(CAS: 1383539-73-8)

HJC0197 is a erythromycin propionate-N-acetylcysteinate inhibitor (EPAC). IC50 value is 5.9 µM for Epac2. HJC0197 can inhibit Epac1-mediated Rap1-GDP exchange a...

CAS 95734-82-0 Nedaplatin

Nedaplatin
(CAS: 95734-82-0)

Nedaplatin is a derivative of cisplatin and DNA damage agent for tumor colony forming units with IC50 of 94 μM.

CAS 29908-03-0 Ademetionine

Ademetionine
(CAS: 29908-03-0)

S-adenosyl-l-methionine (SAMe) is a naturally-occurring substance which is a major source of methyl groups in the brain. The efficacy of SAMe in treating depres...

CAS 100557-06-0 AR12456

AR12456
(CAS: 100557-06-0)

AR12456 is a trapidil derivative. It could protect against serum hyperlipidemia in guinea pigs. It has a strong antilipidemic action in guinea pigs fed a choles...

CAS 53-19-0 Mitotane

Mitotane
(CAS: 53-19-0)

Mitotane, is an antineoplastic medication used in the treatment of adrenocortical carcinoma.

Glutaminase C-IN-1
(CAS: 311795-38-7)

Glutaminase C-IN-1, with effect to suppresse breast cancer cell growth and invasive activity in vitro, it is an allosteric, cell-permeable and reversible inhibi...

CAS 114030-44-3 Dexpemedolac

Dexpemedolac
(CAS: 114030-44-3)

Dexpemedolac is a bio-active chemical compound,but no detailed information is published.

CAS 3771-19-5 Nafenopin

Nafenopin
(CAS: 3771-19-5)

Nafenopin is a hypolipidemic agent, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the ac...

CAS 34552-78-8 Lometraline HCl

Lometraline HCl
(CAS: 34552-78-8)

Lometraline, an aminotetralin derivative, is a potential antidepressant and/or anxiolytic agent.

Gepotidacin
(CAS: 1075236-89-3)

Gepotidacin is a potent Type II DNA topoisomerase inhibitor. It is a novel antibacterial drug candidate. It is used for the treatment of gram positive bacterial...

CAS 19685-09-7 (S)-10-Hydroxycamptothecin

(S)-10-Hydroxycamptothecin
(CAS: 19685-09-7)

10-Hydroxycamptothecin inhibits the growth of BT-20 and MDA-231 cell with IC50 of 34.3 nM and 7.27 nM, respectively, more potently than camptothecin (CPT) with ...

CAS 61303-13-7 Isoacteoside

Isoacteoside
(CAS: 61303-13-7)

Isoacteoside is a natural compound which exhibit significant inhibition of advanced glycation end product formation, compared with those of aminoguanidine and q...

CVT-2551
(CAS: 172430-44-3)

CVT-2551, a piperazineacetamide derivative, could have been useful in some biological studies.

GLPG-1690
(CAS: 1628260-79-6)

GLPG-1690, an imidazopyridine derivative, has been found to be a ENPP2 protein inhibitor that could probably be effective as an anti-inflammatory agent and is u...

CAS 31828-71-4 Mexilitine

Mexilitine
(CAS: 31828-71-4)

Mexiletine is a non-selective voltage-gated sodium channel blocker used to treat arrhythmias within the heart, or seriously irregular heartbeats.

CAS 5915-41-3 Terbuthylazine

Terbuthylazine
(CAS: 5915-41-3)

Terbuthylazine is a triazine herbicide.

CAS 434-13-9 Lithocholic acid

Lithocholic acid
(CAS: 434-13-9)

Lithocholic acid is a toxic secondary bile acid, causes intrahepatic cholestasis, has tumor-promoting activity, its toxic effect can be protected after it activ...

CAS 137-58-6 Lidocaine

Lidocaine
(CAS: 137-58-6)

Lidocaine is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 μM.

Presatovir
(CAS: 1353625-73-6)

Presatovir is a viral fusion protein inhibitor originated by Gilead Sciences with EC50 value of 0.43 nM. GS-5806 can inhibit a broad range of respiratory syncyt...

CAS 72093-21-1 Mastoparan

Mastoparan
(CAS: 72093-21-1)

Mastoparan, a tetradecapeptide which is a component of wasp venom, activates Gi and Go and has been shown to cause an increase in the production of Arachidonic ...

Chemical Structure

CAS 118-08-1 (1R,9S)-(-)-β-Hydrastine

Quick Inquiry

Verification code

Featured Items